Clinical Trial Update: A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) [Phase 2]

View source ↗

Summary

A Phase 2 salvage trial (STARTAR) evaluated androgen receptor inhibition with ADT and apalutamide plus radiation therapy, followed by docetaxel, in men with PSA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Apalutamide (apalutamide)
• DOCETAXEL (DOCETAXEL)
• androgen receptor inhibitor therapy (ADT)

Snippet

Sponsor: Andrew J. Armstrong, MD | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-03-19